Literature DB >> 17980664

Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa.

Niaz Banaiee1, Vanessa January, Charmaine Barthus, Maureen Lambrick, Denise Roditi, Marcel A Behr, William R Jacobs, Lafras M Steyn.   

Abstract

In a prospective study conducted by laboratory technologists in a diagnostic laboratory in Cape Town, South Africa, a semi-automated phage-based antibiotic susceptibility assay was implemented and the performance of the luciferase reporter mycobacteriophage (LRP) system for susceptibility testing of clinical Mycobacterium tuberculosis complex (MTC) isolates against rifampin and isoniazid was evaluated. Two hundred consecutive clinical MGIT cultures of MTC species were included in this study. Antibiotic susceptibility assays were set up manually for the LRP and BACTEC radiometric systems (BACTEC) and read in a plate luminometer and the BACTEC 460 instrument, respectively. Discrepant susceptibility results were resolved by the conventional agar proportion method. Of the 200 secondary cultures prepared for this study, 9 (4.5%) were lost to contamination (LRP 4, BACTEC 1, both 4). All of the remaining 191 cultures underwent susceptibility testing by both methods and the overall agreement between the LRP and BACTEC was 98.4% (rifampin 100%; isoniazid 96.9%). Of the 6 discrepant cultures tested by the agar proportion method, 2 gave results in agreement with the LRP. The sensitivity of the LRP for detection of drug-resistant isolates was 100% for both rifampin (n=9) and isoniazid (n=12). The median turnaround time for susceptibility testing was 2 days with the LRP and 9 days with BACTEC. In conclusion, the semi-automated LRP-based assay offers a rapid and practical approach for accurate susceptibility testing of M. tuberculosis cultures in diagnostic laboratories with limited financial resources, but with competent technologists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17980664      PMCID: PMC3677954          DOI: 10.1016/j.tube.2007.08.006

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  13 in total

Review 1.  The TB epidemic from 1992 to 2002.

Authors:  Mario C Raviglione
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

2.  Does DOTS work in populations with drug-resistant tuberculosis?

Authors:  Kathryn DeRiemer; Lourdes García-García; Miriam Bobadilla-del-Valle; Manuel Palacios-Martínez; Areli Martínez-Gamboa; Peter M Small; José Sifuentes-Osornio; Alfredo Ponce-de-León
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

3.  Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico.

Authors:  N Banaiee; M Bobadilla-Del-Valle; S Bardarov; P F Riska; P M Small; A Ponce-De-Leon; W R Jacobs; G F Hatfull; J Sifuentes-Osornio
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.

Authors:  M A Espinal; S J Kim; P G Suarez; K M Kam; A G Khomenko; G B Migliori; J Baéz; A Kochi; C Dye; M C Raviglione
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

5.  Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification.

Authors:  D De Wit; L Steyn; S Shoemaker; M Sogin
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

6.  Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico.

Authors:  M L García-García; A Ponce de León; M E Jiménez-Corona; A Jiménez-Corona; M Palacios-Martínez; S Balandrano-Campos; L Ferreyra-Reyes; L Juárez-Sandino; J Sifuentes-Osornio; H Olivera-Díaz; J L Valdespino-Gómez; P M Small
Journal:  Arch Intern Med       Date:  2000-03-13

7.  Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tube (MGIT) system.

Authors:  Svetoslav Bardarov; Horng Dou; Katherine Eisenach; Niaz Banaiee; S u Ya; John Chan; William R Jacobs; Paul F Riska
Journal:  Diagn Microbiol Infect Dis       Date:  2003-01       Impact factor: 2.803

8.  Tuberculosis drug resistance: a global threat.

Authors:  Jean B Nachega; Richard E Chaisson
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079

9.  Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates.

Authors:  Manzour Hernando Hazbón; Nora Guarín; Beatriz Eugenia Ferro; Ana Lucía Rodríguez; Luz Angela Labrada; Rafael Tovar; Paul F Riska; William R Jacobs
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

10.  Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages.

Authors:  Niaz Banaiee; Miriam Bobadilla-Del-Valle; Paul F Riska; Svetoslav Bardarov; Peter M Small; Alfredo Ponce-de-Leon; William R Jacobs; Graham F Hatfull; Jose Sifuentes-Osornio
Journal:  J Med Microbiol       Date:  2003-07       Impact factor: 2.472

View more
  6 in total

1.  Evaluation of fluoromycobacteriophages for detecting drug resistance in Mycobacterium tuberculosis.

Authors:  Liliana Rondón; Mariana Piuri; William R Jacobs; Jacobus de Waard; Graham F Hatfull; Howard E Takiff
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

2.  Molecular Genetics of Mycobacteriophages.

Authors:  Graham F Hatfull
Journal:  Microbiol Spectr       Date:  2014-03-07

3.  Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis.

Authors:  Suporn Pholwat; Beeta Ehdaie; Suporn Foongladda; Kimberly Kelly; Eric Houpt
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

4.  Optimisation of bioluminescent reporters for use with mycobacteria.

Authors:  Nuria Andreu; Andrea Zelmer; Taryn Fletcher; Paul T Elkington; Theresa H Ward; Jorge Ripoll; Tanya Parish; Gregory J Bancroft; Ulrich Schaible; Brian D Robertson; Siouxsie Wiles
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

5.  Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis.

Authors:  Mariana Piuri; William R Jacobs; Graham F Hatfull
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

6.  Evaluation of a High-Intensity Green Fluorescent Protein Fluorophage Method for Drug- Resistance Diagnosis in Tuberculosis for Isoniazid, Rifampin, and Streptomycin.

Authors:  Xia Yu; Yunting Gu; Guanglu Jiang; Yifeng Ma; Liping Zhao; Zhaogang Sun; Paras Jain; Max O'Donnell; Michelle Larsen; William R Jacobs; Hairong Huang
Journal:  Front Microbiol       Date:  2016-06-17       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.